American Legion urge Congress to remove Marijuana from schedule I

American Legion adopts Resolution, becomes first Veterans organization to advocate for Cannabis reform.

NINETY-EIGHTH NATIONAL CONVENTION
OF
THE AMERICAN LEGION
Cincinnati, Ohio
August 30, 31, September 1, 2016
Resolution No. 11: Medical Marijuana
Research Origin: Louisiana
Submitted by: Convention Committee on Veterans Affairs & Rehabilitation
WHEREAS, Over the past several years, post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI) have been thrust into the forefront of the consciousness of the medical community and the general public in large part due to recent combat operations and subsequent recognition of these
 potentially ‘silent injuries”; and
WHEREAS, Our foundation of knowledge guiding current diagnostics and interventions of PTSD and TBI has gained through decades of study in the academic medical world; and
WHEREAS, PTSD and TBI produce a complex constellation of medical consequences including physical, emotional, behavioral, and cognitive deficits; and
WHEREAS, The impact is heterogeneous given the varied types of injury (closed, penetrating, blast), severity, comorbid conditions, and premorbid characteristics; and
WHEREAS, The Department of Defense (DoD) and the Department of Veteran Affairs (VA)(May 2007), by consensus, have defined traumatic brain injury as any traumatically induced structural injury and/or physiological disruption of brain function as a result of an external force that is indicted by new onset or worsening of at least one of the following clinical signs, immediately following the event:
1. Any period of loss of or a decreased level of consciousness;
2. Any loss of memory for events immediately before or after the injury;
3. Any alteration in mental state at the time of the injury (e.g., confusion, disorientation, slowed thinking);
4. Neurological deficits (e.g., weakness, balance disturbance, praxis, paresis/plegia, change in vision,other sensory alterations, aphasia) that may or may not be transient;
5. Intracranial lesions; and
WHEREAS, TBI is a leading cause of death and disability in the United States where one and ahalf million Americans incur a traumatic brain injury (TBI) each year 9CDC, 2007); and
WHEREAS, These figures likely underestimate the true incidence of military injuries and those with mid injuries may not seek health care; and
WHEREAS, Direct costs for hospital care, extended care, and other medical care and services,coupled with indirect costs such as lost productivity were estimated at $60 billion annually in 2000 (CDC2007; Finkelstein et al., 2006); and
WHEREAS, These figures do not include the physical, emotional, and social costs to the injured persons and their family from TBI-related disability; and
WHEREAS, For fiscal year 2009, there were1, 313 veterans who received VA inpatient hospitalcare for TBI; and
WHEREAS, The Department of Veteran Affairs defines PTSD as a psychiatric disorder that canoccur following the experience or witnessing of life-threatening events such as military combat, naturaldisasters, terrorist incidents, serious accidents, or violent personal assaults like rape; and
WHEREAS, From April 2007 through fiscal year 2009, thousands of veterans were identified as possibly having PTSD or a TBI through outpatient screening of individuals presenting to the VA for healthcare following deployment in Operation Enduring Freedom or Operation Iraqi Freedom; and
WHEREAS, About 20 years ago, scientist discovered a system in the brain called the endocannabinoid system that responds to 60 chemicals in marijuana, also known as cannabis; and 
WHEREAS, This system plays a role in many of the body’s functions, such as in the heart, along with the digestive, endocrine, immune, nervous, and reproductive systems; and
WHEREAS, This discovery sparked interest in finding specific chemicals made from marijuana
that could be targeted for specific conditions; and
WHEREAS, Marijuana is classified as schedule I drugs and drugs such as cocaine,methamphetamine, methadone, hydromorphone (Dilaudid), meperidine (Demerol), oxycodone(OxyContin), fentanyl, Dexedrine, Adderall, and Ritalin are classified as schedule II drugs; and
WHEREAS, In April 2016, the Drug Enforcement Agency gave its approval to a study on theeffect of medical marijuana on post-traumatic stress disorder, the first randomized, controlled research inthe U.S for PTSD that will use the actual plant instead of oils or synthesized cannabis; now, therefore,
be it RESOLVED, By The American Legion in National Convention assembled in Cincinnati,Ohio, August 30, 31, September 1, 2016, that The American Legion urge the Drug Enforcement Agency to license privately-funded medical marijuana production operations in the United States to enable safe and efficient cannabis drug development research; and,
be it finally,RESOLVED, That The American Legion urge Congress to amend legislation to remove Marijuana from schedule I and reclassify it in a category that, at a minimum will recognize cannabis as a drug with potential medical value.

About Anthony Taylor

Anthony Taylor is a long time activist in the marijuana reform movement. He was responsible for changes to the initiative process and has been a persistent voice in Salem for marijuana reform. His recent efforts led to the addition of PTSD to the list of qualifying conditions for the use of medical marijuana as well as sentencing reform including the creation of misdemeanor possession of marijuana and hashish, a long overdue change in Oregon statute.